Centiva Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $101M | Sell |
4,175,400
-275,200
| -6% | -$7.2M | 0.88% | 22 |
|
|
2026
Q1 | $125M | Buy |
4,450,600
+2,029,500
| +84% | +$54M | 0.92% | 19 |
|
|
2025
Q4 | $60.3M | Buy |
2,421,100
+1,421,100
| +142% | +$35.8M | 0.49% | 42 |
|
|
2025
Q3 | $25.5M | Buy |
+1,000,000
| New | +$24.7M | 0.24% | 74 |
|
|
2024
Q4 | – | Sell |
-7,200
| Closed | -$208K | – | 2231 |
|
|
2024
Q3 | $208K | Sell |
7,200
-13,400
| -65% | -$391K | ﹤0.01% | 1802 |
|
|
2024
Q2 | $576K | Buy |
20,600
+19,000
| +1,188% | +$523K | 0.01% | 1066 |
|
|
2024
Q1 | $44.4K | Sell |
1,600
-36,000
| -96% | -$999K | ﹤0.01% | 1656 |
|
|
2023
Q4 | $1.08M | Buy |
37,600
+27,100
| +258% | +$819K | 0.03% | 585 |
|
|
2023
Q3 | $348K | Buy |
+10,500
| New | +$371K | 0.01% | 1117 |
|
|
2023
Q2 | – | Sell |
-10,200
| Closed | -$416K | – | 1908 |
|
|
2023
Q1 | $416K | Sell |
10,200
-46,900
| -82% | -$2.03M | 0.01% | 916 |
|
|
2022
Q4 | $2.93M | Buy |
57,100
+25,000
| +78% | +$1.2M | 0.08% | 250 |
|
|
2022
Q3 | $1.41M | Buy |
32,100
+10,400
| +48% | +$505K | 0.03% | 477 |
|
|
2022
Q2 | $1.14M | Buy |
21,700
+10,700
| +97% | +$545K | 0.03% | 551 |
|
|
2022
Q1 | $570K | Sell |
11,000
-337,300
| -97% | -$17.5M | 0.01% | 918 |
|
|
2021
Q4 | $20.6M | Buy |
348,300
+328,290
| +1,641% | +$16.3M | 0.42% | 41 |
|
|
2021
Q3 | $863K | Buy |
20,010
+18,010
| +901% | +$798K | 0.05% | 382 |
|
|
2021
Q2 | $78K | Hold |
2,000
| – | – | ﹤0.01% | 1277 |
|
|
2021
Q1 | $72K | Sell |
2,000
-360,500
| -99% | -$12.8M | ﹤0.01% | 1077 |
|
|
2020
Q4 | $13.3M | Buy |
362,500
+257,100
| +244% | +$9.43M | 0.52% | 34 |
|
|
2020
Q3 | $3.67M | Hold |
105,400
| – | – | 0.24% | 68 |
|
|
2020
Q2 | $3.27M | Sell |
105,400
-295,120
| -74% | -$10M | 0.2% | 69 |
|
|
2020
Q1 | $12.4M | Buy |
400,520
+105,400
| +36% | +$3.59M | 0.56% | 16 |
|
|
2019
Q4 | $11M | Buy |
+295,120
| New | +$10.5M | 0.54% | 37 |
|
|
2019
Q1 | – | Sell |
-75,045
| Closed | -$3.11M | – | 358 |
|
|
2018
Q4 | $3.11M | Sell |
75,045
-6,113
| -8% | -$254K | 0.25% | 57 |
|
|
2018
Q3 | $3.39M | Buy |
81,158
+73,253
| +927% | +$2.82M | 0.29% | 53 |
|
|
2018
Q2 | $273K | Sell |
7,905
-51,857
| -87% | -$1.77M | 0.06% | 70 |
|
|
2018
Q1 | $2.01M | Buy |
+59,762
| New | +$2.05M | 0.48% | 19 |
|
Other funds holding PFE
Centiva Capital's PFE Position: Q2 2026 in Review
Centiva Capital increased its Pfizer (PFE) stake by 74% in Q2 2026, buying an estimated $10M and bringing the position to 899,074 shares worth $21.6M. The position accounts for 0.19% of the portfolio, ranked #98.
Centiva Capital first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $22.1M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centiva Capital held 899,074 shares of Pfizer worth $21.6M as of Q2 2026.
- Centiva Capital bought 383,579 Pfizer shares in Q2 2026, an estimated $10M.
- Pfizer made up 0.19% of Centiva Capital's portfolio in Q2 2026, its #98 holding.
- Centiva Capital first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
- Centiva Capital's Pfizer position peaked at $22.1M in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.